JPRN-UMIN000005744
Recruiting
Phase 3
The effect of melatonin or ramelteon for patients with circadian rhythm sleep disorder. - The effect of melatonin or ramelteon for patients with circadian rhythm sleep disorder.
ational Center Hospital, National Center of Neurology and Psychiatry0 sites80 target enrollmentJune 13, 2011
Conditionscircadian rhythm sleep disorder
Overview
- Phase
- Phase 3
- Intervention
- Not specified
- Conditions
- circadian rhythm sleep disorder
- Sponsor
- ational Center Hospital, National Center of Neurology and Psychiatry
- Enrollment
- 80
- Status
- Recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients with active co\-morbidities including severe conditions. Heart failure, liver failure, renal failure, severe infection. Pregnancy, breast feeding and suspected pregnancy. Under treatment of Fluvoxamine Maleate.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Phase 3
melatonin in patients with COVID-19U07.2COVID-19, virus not identifiedCOVID-19 disease.IRCT20200506047323N7Bandare-abbas University of Medical Sciences60
Recruiting
Not Applicable
Effect of melatonin receptor agonist(ramelteon) for sleep disorder with type 2 diabetes mellitusType 2 Diabetes mellitus with sleep disorderJPRN-UMIN000012271Machida Municipal Hospital100
Recruiting
Not Applicable
The effect of melatonin receptor agonist on patients with atopic dermatitisAtopic dermatitisJPRN-UMIN000009707Yokohama City University Graduate School of Medicine20
Recruiting
Phase 3
Melatonin supplementation in treatment of obese children and adolescents with nonalcoholic fatty liver diseaseon alcoholic fatty liver disease (NAFLD).Nonalcoholic steatohepatitis (NASH)K75.81IRCT20200531047614N2Kashan University of Medical Sciences66
Recruiting
Phase 3
Evaluation of the effect of melatonin in the treatment of sepsisIRCT20210825052289N1Ardabil University of Medical Sciences50